智通财经APP讯,兆科眼科-B(06622)发布公告,公司已向国家药品监督管理局取得TONO-i的医疗器械注册证。
TONO-i为一款创新的眼压计,设计特点为免触式、便携及轻便。有别于传统的接触式眼压计,TONO-i可于无需麻醉下,无痛、无感染风险地安全使用。
TONO-i将作为公司旗下青光眼医疗产品组合的重要部分,满足中国低诊断及治疗比率的需求缺口。TONO-i为眼科医生提供一种工具,透过测量轻易、准确及透彻地监察患者的眼压,有助患者提供疗效的即时及持续反馈,提高患者青光眼药物治疗的依从性。TONO-i加入公司的管线,标志着公司在治疗及诊断双管齐下的青光眼管理承诺。
于2022年11月,公司与C&V Tech达成一项有关TONO-i的独家分销协议。C&V Tech为一间于开发诊断、治疗及预防青光眼的医疗器材领域具有领先地位的公司。根据该协议的条款,公司拥有于大中华登记、进口、推广、分销、营销及出售TONO-i的独家权利。该等权利其后透过合约修订扩大至包括泰国及马来西亚,自2024年8月起生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.